EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Slow acting drug therapy of rheumatoid arthritis Treatment duration and side effect profile



Slow acting drug therapy of rheumatoid arthritis Treatment duration and side effect profile



Arthritis & Rheumatism 37(9 SUPPL ): S257




(PDF emailed within 1 workday: $29.90)

Accession: 033411978

Download citation: RISBibTeXText



Related references

Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis. Nurse Practitioner 12(3): 44, 49-52, 1987

Combined slow acting drug treatment a new principle in the treatment of rheumatoid arthritis. Klinicheskaya Meditsina (Moscow) 68(1): 119-124, 1990

The effect of order of second line drug therapy on the development of side effects in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 40(2): 204-205, 1981

Evaluating slow-acting antirheumatic drug therapies for rheumatoid arthritis. Clinical Rheumatology 2(2): 189-195, 1983

Rheumatoid arthritis therapy: the slow-acting agents. Hospital Practice 24(6): 163-8, 170, 173-8, 1989

Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug. Prescrire International 10(52): 36-39, 2001

Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?. Rheumatology 48(3): 316-317, 2009

Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis. Texas Medicine 81(9): 35-39, 1985

Slow-acting drugs do not effect the outcome of rheumatoid arthritis. Balint, G, Gomor, B, Hodinka, L International Congress Series; Rheumatology, state of the art: 309-311, 1992

Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy. Annales D'endocrinologie 71(4): 257-263, 2010

Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis. La Clinica Terapeutica 148(1-2): 7-13, 1997

Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis. New Zealand Medical Journal 111(1067): 200-203, 1998

Slow acting antirheumatic drugs in the treatment of elderly patients with rheumatoid arthritis. Arthritis & Rheumatism 31(4 SUPPL): S79, 1988

Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?. British Journal of Rheumatology 26(2): 103-107, 1987